» Articles » PMID: 1867265

CHARGE Association: Clinical Manifestations and Developmental Outcome

Overview
Journal Am J Med Genet
Specialty Genetics
Date 1991 Apr 1
PMID 1867265
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mental retardation and growth failure are considered integral manifestations in the CHARGE association, reported to be present in as many as 90% of cases. Recent studies have reported a better than expected outcome in some patients; however, the conclusions of these studies have been confounded to some extent by their inclusion criteria. We report follow-up of 17 patients with CHARGE association in whom the diagnosis was based on clinical findings present in early infancy, before developmental patterns were established. Of the 7 survivors, all had motor delay, and 6 had feeding difficulties during infancy. Psychometric assessment at follow-up (age range 2 years, 10 months, to 15 years) showed that 2 were functioning in the normal range, 3 had specific language delay, one had moderate mental retardation, and one had severe mental retardation. Feeding problems persisted in only the 2 youngest patients. After initial failure to thrive, normal height was reached in 4 of 5 children older than age 3 years. The effects of visual and hearing deficits, their management, and the effects of physical illness are discussed with respect to developmental outcome. Our results suggest that some infants with CHARGE association who survive early infancy have a better prognosis for feeding difficulties, growth, and mental development than may be expected from early performance and better than that generally predicted from the current literature. The prompt management of sensory deficits is emphasized.

Citing Articles

Beyond CHD7 gene: unveiling genetic diversity in clinically suspected CHARGE syndrome.

Kim D, Yoon J, Bae H, Hwang S, Seo G, Koh J J Hum Genet. 2025; .

PMID: 40000719 DOI: 10.1038/s10038-025-01325-1.


Phenotypic characteristics and variability in CHARGE syndrome: a PRISMA compliant systematic review and meta-analysis.

Thomas A, Waite J, Williams C, Kirk J, Oliver C, Richards C J Neurodev Disord. 2022; 14(1):49.

PMID: 36045324 PMC: 9429597. DOI: 10.1186/s11689-022-09459-5.


Olfactory Malformations in Mendelian Disorders of the Epigenetic Machinery.

Aleo S, Cinnante C, Avignone S, Prada E, Scuvera G, Ajmone P Front Cell Dev Biol. 2020; 8:710.

PMID: 32850830 PMC: 7417603. DOI: 10.3389/fcell.2020.00710.


Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach.

Dijk D, Bocca G, van Ravenswaaij-Arts C J Multidiscip Healthc. 2019; 12:607-620.

PMID: 31534343 PMC: 6682174. DOI: 10.2147/JMDH.S175713.


Reproductive endocrine phenotypes relating to CHD7 mutations in humans.

Balasubramanian R, Crowley Jr W Am J Med Genet C Semin Med Genet. 2017; 175(4):507-515.

PMID: 29152903 PMC: 5790312. DOI: 10.1002/ajmg.c.31585.